Latest Breaking News On - Meeting of the american rhinologic society - Page 1 : vimarsana.com

Acclarent to Reveal New Data and Innovations to Advance Minimally Invasive ENT Procedures at ARS and AAO 2022 Meetings

Acclarent to Reveal New Data and Innovations to Advance Minimally Invasive ENT Procedures at ARS and AAO 2022 Meetings
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesBryan vaughnZachary cappelloRichard thrasherJeff hopkinsJim atkinsJohnson medtechNithin adappaPat colleyRay weissKaren hoffmannRaj sindwaniAcclarent navigation technologyAmerican academy of otolaryngologyMeeting of the american rhinologic societyWomen physicians to develop optimal practice health

Lyra Therapeutics to Present Additional LANTERN Phase 2 Study Results for LYR‑210 in Two Oral Presentations at ARS Annual Meeting

/PRNewswire/ Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise,.

United statesKathryn morrisMeeting of the american rhinologic societyHealth disparitiesYates networkUniversity of north carolina school medicineLyra therapeutics incLyra therapeuticsAnnual meetingAmerican rhinologic societyPresentation detailsNorth carolina schoolChronic rhinosinusitis histologyDisease burdenChronic rhinosinusitisPrivate securities litigation reform act

Lyra Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

/PRNewswire/ Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise,.

United statesAppointedjim tobinKathryn morrisMaria palasisHarlanw waksalBoston scientific corporationCompany board of directorsBaxter internationalBiogen incMeeting of the american rhinologic societyLyra therapeutics incBoard at transmedics incLyra therapeuticsChief executive officerCombined otolaryngology spring meetingsFourth quarter

Lyra Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

/PRNewswire/ Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise,.

United statesAppointedjim tobinKathryn morrisMaria palasisHarlanw waksalBoston scientific corporationCompany board of directorsBaxter internationalBiogen incMeeting of the american rhinologic societyLyra therapeutics incBoard at transmedics incLyra therapeuticsChief executive officerCombined otolaryngology spring meetingsFourth quarter